Results 171 to 180 of about 36,605 (250)

Engineering an AIEgen-based platform integrating CRISPR/Cas9 to remodel the tumor microenvironment and reinforce photo-immunotherapy against glioblastom. [PDF]

Signal Transduct Target Ther
Luo G, Ma F, Yang Y, Yang C, Li X, Xie J, Xiong K, Chen P, Ma K, Zhao Z, Tang BZ, Duo Y.   +11 more
europepmc   +1 more source

Evaluating the Serum Levels of CD73 in Patients with Head and Neck Squamous Cell Carcinoma. [PDF]

J Dent (Shiraz)
Zare R, Ranjbar MA, Ebrahimi A, Malekzadeh M, Khademi B, Savadi N.   +5 more
europepmc   +1 more source

CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy. [PDF]

Cancer Res Commun
Chandraganti S, Sams C, Sahoo S, Feng B, O'Connell I, Li L, Nepal S, Pulukuri S, Bakhle K, Thiru P, Simian C, Maymi V, Rudd BD, Bell GW, Hatfield S, Jolly MK, Dongre A.   +16 more
europepmc   +1 more source

Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma. [PDF]

Oncoimmunology
Najjar YG, Hong CS, Menshikova EV, Kirkwood JM, Diergaarde B, Jackson EK, Whiteside TL.   +6 more
europepmc   +1 more source

Glycerol-mediated nose-to-brain codelivery of anti-IL-17 and anti-CD73 antibodies enhances immunotherapy for melanoma brain metastases. [PDF]

Sci Adv
Yang X, Yang H, Xu N, Zhu Y, Yun Z, Zhang H, Miao J, Xie Y, Gao L, Ying L, Dong L, Wang Y, Ni Y, Xie J.   +13 more
europepmc   +1 more source

An ITGA11 expressing subpopulation as predictor for the donor-specific osteogenic capacity of stromal cells. [PDF]

Bone Res
Jamil AJM, Madsen K, Daamouch S, Villadsen B, Ma C, Jeromdesella S, Nørgård MØ, Grupe E, Jakobsson MB, Wang Y, Takematsu E, Zhao L, Goodman SB, Goodnough LH, Chan CKF, Andersen TL, Kassem M, Rauch A.   +17 more
europepmc   +1 more source

Descriptive study of stromal expression of CD73 in ductal carcinoma in situ of the breast. [PDF]

Discov Oncol
Catteau X, Noël JC, Fallas J, Charry M, Denis Z, De Caluwé A, Stagg J, Sotiriou C, Buisseret L.   +8 more
europepmc   +1 more source

Expression and prognostic impact of CD73 in classical Hodgkin lymphoma. [PDF]

Ann Hematol
Liu B, He C, Liu H, Ma G, Zhang S, Liu Y, Liu C, Li K, Wang Y, Liu Y, Yue M, Liu C, Wang X, Yin S, Li Z.   +14 more
europepmc   +1 more source

CD73 activity controls cytotoxic CD4 T-cell response driving myocardial pathology in chronic Chagas disease. [PDF]

Front Immunol
Bergero G, Mazzocco YL, Cejas Gallardo ZM, Rivarola W, Del Rosso S, Aoki MP.   +5 more
europepmc   +1 more source

Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapy. [PDF]

Mol Ther Oncol
McClellan BL, Peña Agudelo JA, Mujeeb AA, Dabaja AA, Zhu Z, Raghuram S, Varela ML, Tronrud C, Banerjee K, Wei A, Calatroni C, Zhang LH, Romero LC, Oh P, Alghamri MS, Robbins A, Perricone M, Wang Y, Shay B, Sajjakulnukit P, Lyssiotis CA, Welch JD, Schwendeman A, Lowenstein PR, Castro MG.   +24 more
europepmc   +1 more source